Social determinants of health (SDH), such as socioeconomic status and educational background are factors that are ...

These manifestations are often part of the systemic activity or flare, which can be painful and have a considerable impact on quality of life,” said principal investigator Prof. Eric Morand, from ...

EULAR – The European Alliance of Associations for Rheumatology – acknowledges the impact of socioeconomic factors on the persistence of rheumatic and musculoskeletal diseases (RMD), and the society’s ...

Six of the patients, of whom four had non-renal SLE, had follow-up of at least 24 weeks. Of those, five showed dramatic ...

BARCELONA -- A novel antibody-based drug targeting the CD40 ligand helped close to half of patients with treatment-refractory systemic lupus erythematosus (SLE) get symptoms under control, according ...

UCB and Biogen's lupus candidate showed strong Phase 3 results, including fatigue improvement and higher remission versus ...

Social determinants of health (SDH), such as socioeconomic status and educational background are factors that are increasingly recognised as critical ...

PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) has unveiled new clinical and translational data from its ongoing RESET ...

Merck KGaA has shed more light on the failure of its lupus drug in one cohort of patients, while pointing to secondary ...

BDC Advisors, a leading healthcare strategy consulting firm, is pleased to announce the appointment of Carrie Knowles-Atkinson as a Principal. Carrie brings over 25 years of leadership in provider ...

Although it did not meet the primary endpoint of dose-response relationship, when compared to placebo, enpatoran demonstrated improvements in measures of both systemic and cutaneous disease activity ...